What is the TCRX stock price prediction for next 2 weeks?

According to our price prediction algorithm,TScan Therapeutics, Inc. (TCRX) price will be around $1.10 in the next 2 weeks. This means it will increase by 10.460000000000003 from the last closing price. This prediction may vary from other time period filters for TCRX stock.

What can be the highest Possible price of TCRX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, TCRX can achieve the highest price of $1.19 which is 19.296673356316862 higher than last closing price. This prediction may vary from other time period filters for TCRX stock.

What can be the lowest Possible price of TCRX stock in next 2 weeks?

As per the forecast and algorithmic analysis, TCRX stock price can be as low as $1.02 which is 2.3112652691880786 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for TCRX stock.

Will TCRX stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that TCRX stock will gain10.460000000000003 in the next 2 weeks. This prediction may vary from other time period filters for TCRX stock.

What is TCRX stock last closing price?

Last closing price of TCRX stock was $1.00.

What is TCRX stock price prediction?

TCRX stock price prediction means predicting the future closing prices of TCRX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of TCRX stock in a certain time period.

How we predict TCRX stock future prices?

If you are searching for TCRX stock forecast, analysis or price prediction, then you might be wondering what TScan Therapeutics, Inc. (TCRX) will do in the future. Our TCRX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This TCRX price prediction will likely answer most of your questions.

How frequent we update TCRX stock predictions?

We are updating the forecasts for the TCRX stock on daily basis.

Is using ML forecasting for TCRX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for TCRX stock same for all the time periods?

No, the prediction for TCRX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

TScan Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.00-13.79%Since 2 Weeks

Predicted Price$1.1010.46%For 2 Weeks

Upper Predicted Price$1.1919.3%For 2 Weeks

Lower Predicted Price$1.022.31%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of TCRX will rise by +10.46% over the next 2 Weeks and hit $1.10 by Friday, May 29, 2026. In that time frame, TCRX's share price is expected to range between $1.02 and $1.19.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 29, 2026	1.02	1.10	1.19
May 28, 2026	1.01	1.10	1.18
May 27, 2026	1.02	1.11	1.20
May 26, 2026	1.02	1.11	1.20
May 25, 2026	1.04	1.13	1.22
May 22, 2026	0.99	1.08	1.17
May 21, 2026	0.98	1.07	1.17
May 20, 2026	0.99	1.08	1.18
May 19, 2026	0.99	1.09	1.17
May 18, 2026	1.02	1.10	1.20

TCRX shares fell -9.91% in Friday, May 15, 2026's trading session, dropping from a previous close of $1.11 to move at $1.00. The stock demonstrated notable intraday movement (see TCRX's key stats for a full breakdown), fluctuating between $1.00 and $1.08, a +8.00% trading range. While recent weeks have seen some volatility, TCRX has managed to secure a -18.03% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 840.89K shares changing hands, 31.97K fewer than the previous session. This amounted to $840.89K in total market activity.

Will TCRX Continue Its Upward Trend?

According to analyst ratings and projections for TCRX, TScan Therapeutics, Inc. shares are anticipated to increase by +16.18%, potentially reaching $1.19 per share by May 29, 2026. Short-term technical indicators currently suggest a neutral sentiment for TCRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the TCRX stock forecast, now is a good time to buy TCRX stock because its current trading price is -9.47% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on TCRX covering social and institutional perspectives.

TCRX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into TCRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 30.25% to 41.79%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.23%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.22%, maintains a neutral outlook for the long term. Insights into TCRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

TScan Therapeutics Short-Term Forecasts

TCRX Forecast For Next 5 Days

Our algorithm anticipates TScan Therapeutics (TCRX) stock could hit $1.19 by May 22, 2026. This represents a +19.44% fall from today's price, following a -4.27% change over the past five days.

TCRX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for TScan Therapeutics, Inc. (TCRX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.21, which would mean a +21.00% increase from the current price of $1.00. Projections for this period range from a high of $1.40 to a low of $1.05.

TCRX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for TScan Therapeutics's price over the next three months point to a rise. TCRX stock is expected to peak at $3.43 on May 20, 2026 before potentially dipping to $1.60 on Aug 14, 2026. On average, TCRX is likely to trade around $2.58 in the coming 90 days.

TScan Therapeutics Stock Forecast 2025

Based on our predictive models, TScan Therapeutics (TCRX) is expected to trade between $0.00 and $3.43 throughout 2026. This would result in an average price of $2.00, potentially offering investors a +100.00% return from current levels.

TScan Therapeutics, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, TScan Therapeutics, Inc. (TCRX) is positioned to show a strong performance in May 2026. The price is predicted to move between $2.91 and $3.43, settling at an average of $3.19. This could translate to a +219.00% gain.

June 2026

Based on current market signals, TScan Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $2.35 to $3.26, with a likely average price of $2.87. Investors could expect a potential return of +187.00%.

July 2026

Our predictive algorithms indicate TScan Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $1.92–$2.59, with an average target of $2.28. This represents a positive outlook and a possible gain of +128.00%.

August 2026

Analyzing established trends, TScan Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $1.59 and $2.29, averaging around $1.99. This suggests a +99.00% gain from current levels.

September 2026

Market indicators suggest TScan Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $1.23 to $2.01, with a midpoint forecast of $1.80. The stock might deliver a +80.00% gain.

October 2026

Forecasting for October 2026, models estimate that TScan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.80 and $1.76, averaging $1.70. This signals a positive trajectory with potential returns around +70.00%.

November 2026

According to our latest forecast models, TScan Therapeutics, Inc. (TCRX) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.44 and $1.59, settling at an average of $1.63. This could translate to a +63.00% gain.

December 2026

Based on current market signals, TScan Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $1.27, with a likely average price of $1.20. Investors could expect a potential return of +20.00%.

January 2027

Our predictive algorithms indicate TScan Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$0.60, with an average target of $1.07. This represents a positive outlook and a possible gain of +7.00%.

February 2027

Analyzing established trends, TScan Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $0.30, averaging around $1.02. This suggests a +2.00% gain from current levels.

March 2027

Market indicators suggest TScan Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $1.01. The stock might deliver a +1.00% gain.

April 2027

Forecasting for April 2027, models estimate that TScan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.93. This signals a cautious trajectory with potential returns around -7.00%.

May 2027

According to our latest forecast models, TScan Therapeutics, Inc. (TCRX) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.90. This could translate to a -10.00% loss.

TCRX's history of dividends and stock splits also plays a role in long-term investor confidence.